Articles from Allotex, Inc.

Allotex Five-Year Clinical Results on Its TransForm Human Tissue Platform
Allotex today announced five-year clinical observations presented in an ESCRS Free Paper by Cafer Tanrıverdi, MD, and collaborators from Medipol University and other clinical institutions in Istanbul. The study evaluated sterile human corneal tissue profiles prepared according to physician-defined geometries and placed in eyes described by the investigators as hyperopic.
By Allotex, Inc. · Via Business Wire · October 23, 2026